Significance and origin of DOPA, DOPAC, and dopamine-sulphate in plasma, tissues and cerebrospinal fluid

Danish Medical Bulletin

Volumn 51, Issue 1, 2004, Pages 34-62

  Eldrup, Ebbe ^a,b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BENSERAZIDE; CARBIDOPA; CLONIDINE; DOPA; DOPAMINE; NORADRENALIN;

ADRENAL MEDULLECTOMY; ADRENERGIC SYSTEM; ANIMAL TISSUE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENTIATION; DRUG TISSUE LEVEL; FOOD DRUG INTERACTION; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PARKINSON DISEASE; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPATHECTOMY;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENAL MEDULLA; ANIMALS; DIHYDROXYPHENYLALANINE; DOGS; DOPAMINE; EATING; EPINEPHRINE; HUMANS; MUSCLE, SKELETAL; NOREPINEPHRINE; RATS; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM;

EID: 4944228709     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (347)

1. Abrahamsen J, Lyck B, Helgestad J, Frederiksen PB 1995 The impact of 123I-meta-iodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma. Acta Oncol 34:505-510.
2. Ahlskog JE, Uitti RJ, Tyce GM, O'Brien JF, Petersen RC, Kokmen E 1996a Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's disease. J Neurol Sci 136:162-168.
3. Ahlskog JE, Uitti RJ, Low PA, Tyce GM, O'Brien JF, Nickander KK 1996b Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease. Neurology 46:796-801.
4. Alvarado CS, Faraj BA, Kim TH, Camp VM, Bain RP, Ragab AH 1985 Plasma dopa and catecholamines in the diagnosis and follow-up of children with neuroblastoma. Am J Pediatr Hematol Oncol 7:221-227.
5. Andersen B, Holm P 1984 Problems with p. Significance testing in medical research. Editiones Roche, Basle.
6. Andén NE, Grabowska-Andén M 1983 Formation of deaminated metabolites of dopamin.e in noradrenaline neurones. Naunyn-Schmiedeberg's Arch Pharmacol 324:1-6.
7. Andén NE, Grabowska-Andén M, Lindgren S, Oweling M 1985 Very rapid turnover of dopamine in noradrenaline cell body regions. Naunyn-Schmiedeberg's Arch Pharmacol 329:258-263
8. Andén NE, Grabowska-Andén M, Schwieler J 1989 Transfer of DOPA from the sympatho-adrenal system to the pancreas, liver and kidney via the blood circulation. Acta Physiol Scand 136:75-79.
9. Andrich MP, Shalaby-Rana E, Movassaghi N, Majd M 1996 The role of 131 iodine-metaiodobenzylguanidine scanning in the correlative imaging of patients with neuroblastoma. Pediatrics 97:246-250.
10. Anton AH, Sayre DF 1962 A study of the factors affecting the aluminum oxide-trihydroxyindole precedure for the analysis of catecholamines. J Pharmacol Exp Ther 138:360-375.
11. Anton AH 1987 Dopamine sulfoconjugate: A catecholamine Gordian knot (editorial). J Lab Clin Med 109:523-525.
12. Anton AH 1991 Is plasma DOPA a valid indicator of sympathetic activity? (editorial). J Lab Clin Med 117:263-264.
13. Anton AH, Sayre DF 1964 The distribution of dopamine and dopa in various animals and a method for their determination in diverse biological material. J Pharmacol Exp Ther 145:326-336.
14. Axelrod FB, Goldstein DS, Holmes C, Berlin D, Kopin IJ 1996 Pattern of plasma levels of catecholamines in familial dysautonomia. Clin Autonom Res 6:205-209.
15. Baily RG, Prophet SA, Shenberger JS, Zelis R, Sinoway LI 1990 Direct neurohumeral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading. Circ Res 66:1720-1728.
16. Banwart B, Miller TD, Jones JD, Tyce GM 1989 Plasma dopa and feeding. Proc Soc Exp Biol Med 191:357-361.
17. Bartlett WA 1989 Effects of mobile phase composition on the chromatographic and electrochemical behaviour of catecholamines and selected metabolites. Reversed-phase ion-paired high-performance liquid chromatography using multiple-electrode detection. J Chromatogr 493:1-14.
18. Bell C 1988 Dopamine release from sympathetic nerve terminals. Prog Neurobiol 30:193-208.
19. Berger PA, Faull KF, Kilkowski J, Anderson PJ, Kraemer H, Davis KL, Barchas JD 1980 CSF monoamine metabolites in depression and schizophrenia. Am J Psychiat 137:174-180.
20. Berthold F, Hunneman DH, Harms D, Kaser H, Zieschang J 1992 Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma. Eur J Cancer 28A:1950-1954.
21. Best JD, Halter JB 1982 Release and clearance rates of epinephrine in man: importance of arterial measurements. J Clin Endocrinol Metab 55:263-268.
22. Bond JV 1975 Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma. Arch Dis Child 50:691-695.
23. Boomsma F, van der Hoorn FAJ, Man in't Veld AJ, Schalekamp ADH 1988 Determination of 3,4-dihydroxyphenylalanine (DOPA) in plasma and cerebrospinal fluid by high performance liquid chromatography with electrochemical detection. Clin Chem Acta 178:59-70.
24. Boomsma F, Ausema L, Hakvoort-Cammel FG, Oosterom R, Man in't Veld AJ, Krenning EP, Hahlen K, Schalekamp MA 1989 Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma. Eur J Cancer Clin Oncol 25:1045-1052.
25. Boomsma F, Alberts G, van Eijk L, Man in't Veld AJ, Schalekamp MA 1993 Optimal collection and storage conditions for catecholamine measurements in human plasma and urine. Clin Chem 39:2503-2508.
26. Bouloux P, Perrett D, Besser GM 1985 Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 22:194-203.
27. Boulton AA, Eisenhofer G 1998 Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. Adv Pharmacol 42:273-292.
28. Bradley JV 1968 Distribution-free statistical tests.Prentice-Hall, Englewood Cliffs, New Jersey.
29. Bravo EL, Tarazi RC, Fouad FM, Vidt DG, Gifford RW 1981 Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med 305:623-626.
30. Brent PJ, Hall S, Henry DA, Smith AJ 1985 Stability of norepinephrine in blood. Clin Chem 31:659-660.
31. Brodeur GM, Castleberry RP 1997 Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology.Lippincott-Raven, Philadelphia:761-797.
32. Brown MJ, Dollery CT 1981 A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol 11:79-83.
33. Burke D, Sundlöf G, Wallin BG 1977 Postural effects on muscle nerve sympathetic activity in man. J Physiol 272:399-414.
34. Buu NT, Kuchel O 1977 A new method for the hydrolysis of conjugated catecholamines. J Lab Clin Med 90:680-685.
35. Bäck N, Ahonen M, Soinila S, Kivilaakso E, Kiviluoto T 1995 Catecholamine-synthesizing enzymes in the rat stomach. Histochem Cell Biol 104:63-67.
36. Candito M, Krstulovic AM, Sbirazzuoli V, Chambon P 1990 Proposal for the standardization of the calibration method for the assay of plasma catecholamines. J Chromatogr 526:194-202.
37. Candito M, Krstulovic AM, Chambon P 1995 Stability of 3,4-dihydroxyphenylacetic acid in plasma extracts assayed by high-performance liquid chromatography with electrochemical detection. J Chromatogr B 669:413-415.
38. Candito M, Bree F, Krstulovic AM 1996 Plasma catecholamine assays: calibration with spiked plasma versus aqueous solutions. Biomed Chromatogr 10:40-42.
39. Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV 1972 Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch Pharmacol 275:153-168.
40. Carruthers M, Conway N, Somerville W, Taggart P, Bates D 1970 Validity of plasma-catecholamine estimations. Lancet 1:62-67.
41. Castillo J, Martínez F, Suárez C, Naveiro J, Lema M, Nozaki Y 1996 Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients. Cephalalgia 16:56-61.
42. Cederbaum JM 1987 Clinical pharmacokinetics of anti-parkinsonian drugs. Clin Pharmacokinetics 13:141-178.
43. Chen YK, Richter HM, Go VL, Tyce GM 1993 Free and conjugated catecholamines and serotonin in canine thoracic duct lymph: effects of feeding. Am J Physiol (Endocrinol Metab) 265:E184-E189.
44. Chia L-G, Cheng F-C, Kuo J-S 1993 Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease. J Neurol Sci 116:125-134
45. Christensen NJ 1972 Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects. J Clin Invest 51:779-787.
46. Christensen NJ 1973a A sensitive assay for the determination of dopamine in plasma. Scand J Clin Lab Invest 31:343-346.
47. Christensen NJ 1973b Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med Suppl 42:163-171.
48. Christensen NJ 1991 The biochemical assessment of sympathoadrenal activity in man. Clin Autonom Res 1:167-172.
49. Christensen NJ, Neubauer B, Brandsborg O, Mathias CJ, Frankel HL 1975 Letter: Dopamine and the peripheral autonomic nervous system. Lancet 1:1084-1085.
50. Christensen NJ, Vestergaard P, Sorensen T, Rafaelsen OJ 1980 Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiat Scand 61:178-182.
51. Christensen NJ, Henriksen JH 1988 Total norepinephrine spillover. Hypertension 12:468-469.
52. Christensen NJ, Norsk P 2000 Sympathoadrenal activity is increased in humans during spaceflight. In: De Santo NG, Cirillo M, Papalia T, De Napoli N (eds) EDEMA. From bench to clinic. The Telesio Conference 2000. Istituto Italiano per gli Studi Filosofici, Cosenza, Italy:257-263.
53. Clark BA, Rosa RM, Epstein FH, Young JB, Landsberg L 1992 Altered dopaminergic responses in hypertension. Hypertension 19:589-594.
54. Claustre J, Pequignot JM, Bui-xuan B, Muchada R, Cottet-Emard RM, Peyrin L 1990 Conjugation and deamination of circulating dopamine: relationship between sulfated and free dopamine in man. J Auton Nerv Syst 29:175-181.
55. Clerico A, Jenkner A, Castello MA, Ciofetta G, Lucarelli C, Codini M 1991 Functionally active ganglioneuroma with increased plasma and urinary catecholamines and positive iodine 131-meta-iodobenzylguanidine scintigraphy. Med Pediatr Oncol 19:329-333.
56. Cole M, Craft AW, Parker L, Bell S, Seviour JA, McGill AC, Dale G 1995 Urinary creatinine adjusted reference ranges for homovanillic and vanillylmandelic acid in children and adults. Clin Chim Acta 236:19-32.
57. Conolly ME, Davies DS, Dollery CT, Morgan CD, Paterson JW, Sandler M 1972 Metabolism of isoprenaline in dog and man. Br J Pharmacol 46:458-472.
58. Cryer PE, Santiago JV, Shah S 1974 Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. J Clin Endocrinol Metab 39:1025-1029.
59. Cuche JL, Prinseau J, Selz F, Ruget G, Tual JL, Reingeissen L, Devoisin M, Baglin A, Guédon J, Fritel D 1985 Oral load of tyrosine or l-dopa and plasma levels of free and sulfoconjugated catecholamines in healthy men. Hypertension 7:81-89.
60. Cuche JL, Brochier P, Klioua N, Poirier MF, Cuche H, Benmiloud M, Loo H, Safar M 1990 Conjugated catecholamines in human plasma: where are they coming from? J Lab Clin Med 116:681-686.
61. D'Eril GVM, Rizzo V 1991 Determination of free DOPA and 3-O-methyl-DOPA in human plasma by high-performance liquid chromatography with electrochemical detection. J Chromatogr 553:265-269.
62. Da Prada M, Zürcher G 1976 Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19:1161-1174.
63. Da Prada M, Kettler R, Zürcher G 1984 Dekarboxylasehemmung nach Benserazid oder Carbidopa bei Ratten und Menschen: Boichemische Effekte beider Hemmer in Kombination mit Levodopa als Madopar 125 oder als Sinemet 125 im menschlichen Plasma. In: Fischer PA (ed) Vegitativstörungen beim Parkinson-Syndrom.Editiones Roche, Basel:297-310.
64. Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE 1987 Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers. Eur Neurol 27 Suppl 1:9-20.
65. Daniel PM 1977 The metabolic homaeostatic role of muscle and its function as a store of protein. Lancet 2:446-448.
66. Davidson L, Vandongen R, Beilin LJ 1981 Effect of eating bananas on plasma free and sulfateconjugated catecholamines. Life Sci 29:1773-1778.
67. Davies CL, Molyneux SG 1982 Routine determination of plasma catecholamines using reversed-phase, ion-pair high-performance liquid chromatography with electrochemical detection. J Chromatogr 231:41-51.
68. de Jong AP, Kok RM, Cramers CA, Wadman SK, Haan E 1988 A new method for the determination of L-dopa and 3-O-methyldopa in plasma and cerebrospinal fluid using gas chromatography and electron capture negative ion mass spectrometry. Clin Chim Acta 171:49-61.
69. Demassieux S, Corneille L, Lachance S, Carriere S 1981 Determination of free and conjugated catecholamines and L-3,4-dihydroxyphenylalanine in plasma and urine: evidence for a catechol-O-methyltransferase inhibitor in uraemia. Clin Chim Acta 115:377-391.
70. Devalon ML, Miller TD, Squires RW, Rogers PJ, Bove AA, Tyce GM 1989 Dopa in plasma increases during acute exercise and after exercise training. J Lab Clin Med 114:321-327.
71. Devinsky O, Emoto S, Goldstein DS, Stull R, Porter RJ, Theodore WH, Nadi NS 1992 Cerebrospinal fluid and serum levels of DOPA, catechols, and monoamine metabolites in patients with epilepsy. Epilepsia 33:263-270.
72. Dingemanse J, Kneer J, Wallnofer A, Kettler R, Zürcher G, Koulu M, Korn A 1996 Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline. Clin Neuropharmacol 19:399-414.
73. Dingemanse J, Kleinbloesem CH, Zürcher G, Wood ND, Crevoisier C 1997 Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics. Br J Clin Pharmacol 44:41-48
74. Dizdar N, Henriksson A, Kaagedal B 1991 Determination of L-3,4-dihydroxyphenylalanine in biological fluids and tissues. J Chromatogr 565:1-26.
75. Dong WX, Schneider J, Lacolley P, Brisac AM, Safar M, Cuche JL 1993 Neuronal metabolism of catecholamines: plasma DHPG, DOMA and DOPAC. J Auton Nerv Syst 44:109-117.
76. Duncan MW, Smythe GA, Nicholson MV 1984 Comparison of high-performance liquid chromatography with electrochemical detection and gas chromatography-mass fragmentography for the assay of salsolinol, dopamine and dopamine metabolites in food and beverage samples. J Chromatogr 336:199-209.
77. Dunne JW, Davidson L, Vandongen R, Beilin LJ, Rogers P 1983 The effect of ascorbic acid on plasma sulfate conjugated catecholamines after eating bananas. Life Sci 33:1511-1517.
78. Ebinger G, Michotte Y, Herregodts P 1987 The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid. J Neurochem 48:1725-1729.
79. Ehrenström F 1988 Determinations of catechols in small volumes of plasma using ion-pair reversed phase liquid chromatography/electrochemistry. Life Sci 43:615-627.
80. Ehrhardt JD, Schwartz J 1978 A gas chromatography-mass spectrometry assay of human plasma catecholamines. Clin Chim Acta 88:71-79.
81. Eide I, Kolloch R, De Quattro V, Miano L, Dugger R, Van der Meulen J 1979 Raised cerebrospinal fluid norepinephrine in some patients with primary hypertension. Hypertension 1:255-260.
82. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ 1986 Simultaneous liquid-chromatographic determination of 3,4- dihydroxyphenylglycol, catecholamines, and 3,4- dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 32:2030-2033.
83. Eisenhofer G, Goldstein DS, Ropchak TG, Kopin IJ 1988 Source and physiological significance of plasma 3,4- dihydroxyphenylalanine in the rat. J Neurochem 51:1204-1213.
84. Eisenhofer G, Brush JE, Cannon III RO, Stull R, Kopin IJ, Goldstein DS 1989 Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. J Clin Endocrinol Metab 68:247-255.
85. Eisenhofer G, Meredith IT, Ferrier C, Cox HS, Lambert G, Jennings GL, Esler MD 1991 Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover. J Lab Clin Med 117:266-273.
86. Eisenhofer G, Smolich JJ, Esler MD 1992 Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs. Neurochem Int 21:37-44.
87. Eisenhofer G, Åneman A, Friberg P, Hooper D, Fåndriks L, Lonroth H, Hunyady B, Mezey E 1997 Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:3864-3871.
88. Eisenhofer G, Rundqvist B, Friberg P 1998 Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. Am J Physiol (Regulatory Integrative Comp Physiol) 274:R626-R634.
89. Eisenhofer G, Coughtrie MWH, Goldstein DS 1999 Dopamine sulphate: an enigma resolved. Clin Exp Pharmacol Physiol 26(suppl):S41-S53.
90. Eklundh T, Eriksson M, Sjöberg S, Nordin C 1996 Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. J Psychiat Res 30:201-208.
91. Eldeeb BB, Hammond EM, Worthington DJ, Mann JR 1988 Urinary catecholamines and their metabolites in management of neuroblastoma. Pediatr Hematol Oncol 5:229-237.
92. Eldrup E, Hagen C, Christensen NJ, Ølgaard K 1988 Plasma free and sulfoconjugated dopamine in man: Relationship to sympathetic activity, adrenal function and meals. Dan Med Bull 35:291-294.
93. Eldrup E, Richter EA, Christensen NJ 1989a DOPA, norepinephrine, and dopamine in rat tissues: no effect of sympathectomy on muscle DOPA. Am J Physiol (Endocrinol Metab) 256:E284-E287.
94. Eldrup E, Christensen NJ, Andreasen J, Hilsted J 1989b Plasma dihydroxyphenylalanine (DOPA) is independent of sympathetic activity in humans. Eur J Clin Invest 19:514-517.
95. Eldrup E, Hetland ML, Christensen NJ 1994 Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans. Eur J Clin Invest 24:205-211.
96. Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ 1995 CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease. Acta Neurol Scand 92:116-121.
97. Eldrup E, Møller SE, Andreasen J, Christensen NJ 1997 Effects of ordinary meals on plasma concentrations of 3,4-dihydroxyphenylalanine, dopamine sulphate and 3,4-dihydroxyphenylacetic acid. Clin Sci 92:423-430.
98. Eldrup E, Richter EA, Hetland ML, Andreasen J, Hilsted J, Møller SE, Christensen NJ 1998 Origin and significance of plasma dihydroxyphenylalanine. Adv Pharmacol 42:851-854.
99. Eldrup E, Richter EA 2000 Dopa, dopamine, and dopac concentrations in the rat gastrointestinal tract decrease during fasting. Am J Physiol (Endocrinol Metab) 279:E815-E822.
100. Eldrup E, Clausen N, Scherling B, Schmiegelow K 2001 Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma. Scand J Clin Lab Invest 61:479-490.
101. Elman I, Goldstein DS, Adler CM, Shoaf SE, Breier A 2001 Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men. Life Sci 68:1889-1898.
102. Elrod R, Peskind ER, DiGiacomo L, Brodkin KI, Veith RC, Raskind MA 1997 Effects of Alzheimer's disease severity on cerebrospinal fluid norepinephrine concentration. Am J Psychiat 154:25-30.
103. Engelman K, Portnoy B 1970 A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels. Circ Res 26:53-57.
104. Eriksson BM 1989 Assay of catecholamines and related compounds in biological samples with emphasis on liquid chromatography and electrochemical detection. In: The Dean of the Faculty of Pharmacy (ed) Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy.Almqvist & Wiksell Int, Stockholm:1-45.
105. Eriksson BM 1993 Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection, by B.-M. Eriksson and B.-A. Persson, J Chromatogr., 228 (1982) 143. J Chromatogr 612:1-5.
106. Eriksson BM, Persson BA 1982 Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J Chromatogr 228:143-154.
107. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G 1988 Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3-20.
108. Fagius J, Berne C 1989 Changes of sympathetic nerve activity induced by 2-deoxy-D-glucose infusion in humans. Am J Physiol (Endocrinol Metab) 256:E714-E720.
109. Favrot MC, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T 1996 Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group. Ann Oncol 7:607-611.
110. Fekete M, Tárczy M, Bihari K, Katona G 1984 Dopamine/l-dopa ratio in cerebrospinal fluid of parkinsonian patients treated with l-dopa + benserazide. Psychopharmacology 82:93-94.
111. Fillenz M 1990 Noradrenergic Neurons.Cambridge University Press, New York:109-124.
112. Fogel WA 1990 Mucosal mono- and polyamine oxidase activities in digestive tract are distributed complementary to diamine oxidase. J Neural Transmission (Suppl) 32:345-349.
113. Frandsen H, Berne C, Fagius J, Niklasson F, Christensen NJ, Hilsted J 1989 Plasma volume substitution does not inhibit plasma noradrenaline and muscle nerve sympathetic responses to insulin-induced hypoglycaemia in healthy humans. Scand J Clin Lab Invest 49:573-581.
114. Gahr M, Hunneman DH 1987 The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children. Eur J Pediatr 146:489-493.
115. Garty M, Stull R, Kopin IJ, Goldstein DS 1989a Skin color, aging, and plasma L-dopa levels. J Auton Nerv Syst 26:261-263.
116. Garty M, Deka-Starosta A, Chang PC, Eisenhofer G, Zukowska-Grojec Z, Stull R, Kopin IJ, Goldstein DS 1989b Plasma levels of catechols during reflexive changes in sympathetic nerve activity. Neurochem Res 14:523-531.
117. Garty M, Deka-Starosta A, Stull R, Kopin IJ, Goldstein DS 1989c Plasma levels of catechols after fasting in intact or adrenal-demedullated rats. J Auton Nerv Syst 26:181-184.
118. Gaudin C, Braillon A, Selz F, Cuche JL, Lebrec D 1990 Free and conjugated catecholamines in patients with cirrhosis. J Lab Clin Med 115:589-592
119. Geracioti jr TD, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN 1994 Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies. Neuroendocrinol 60:635-642.
120. Gitlow SE, Dziedzic LB, Strauss L, Greenwood SM, Dziedzic SW 1973 Biochemical and histologic determinants in the prognosis of neuroblastoma. Cancer 32:898-905.
121. Gjerris A, Gjerris F, Sørensen PS, Sørensen EB, Christensen NJ, Fahrenkrug J, Rehfeld JF 1988 Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain level. Acta Neurochir 91:55-59.
122. Goldstein DS 1986 Sample handling and preparation for liquid chromatography and electrochemical assays for plasma catecholamines. In: Krstulovic AM (ed) Quantitative analysis of catecholamines and related compounds.Ellis Horwood Ltd, Chichester:126-136.
123. Goldstein DS 1995 Stress, Catecholamines, and Cardiovascular Disease. Oxford University Press Inc., New York: a:p125;b:p128;c:p139; d:p143+230;e:p236;f:p256-7;g:263-4;h:272-3.
124. Goldstein DS, Feuerstein GZ, Kopin IJ, Keiser HR 1981a Validity of liquid chromatography with electrochemical detection for measuring dopamine in human plasma. Clin Chim Acta 117:113-120.
125. Goldstein DS, Feuerstein G, Izzo JLj, Kopin IJ, Keiser HR 1981b Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 28:467-475.
126. Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ 1983 Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 5:552-559.
127. Goldstein DS, Stull R, Zimlichman R, Levinson PD, Smith H, Keiser HR 1984 Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection. Clin Chem 30:815-816.
128. Goldstein DS, Stull R, Eisenhofer G, Sisson JC, Weder A, Averbruch SD, Keiser HR 1986 Plasma 3,4-dihydroxyphenylalanine (Dopa) and catecholamines in neuroblastoma or pheochromocytoma. Ann Intern Med 105:887-888.
129. Goldstein DS, Udelsman R, Eisenhofer G, Stull R, Keiser HR, Kopin IJ 1987a Neuronal source of plasma dihydroxyphenylalanine. J Clin Endocrinol Metab 64:856-861.
130. Goldstein DS, Zimlichman R, Kelly GD, Stull R, Bacher JD, Keiser HR 1987b Effect of ganglion blockade on cerebrospinal fluid norepinephrine. J Neurochem 49:1484-1490.
131. Goldstein DS, Eisenhofer G 1988 Plasma catechols - what do they mean? News Physiol Sci 3:138-144.
132. Goldstein DS, Stull R, Eisenhofer G, Gill JR 1989a Urinary excretion of dihydroxy-phenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci 76:517-522.
133. Goldstein DS, Polinsky RJ, Garty M, Robertson D, Brown RT, Biaggioni I, Stull R, Kopin IJ 1989b Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 26:558-563.
134. Goldstein DS, Cannon III RO, Quyyumi A, Chang P, Duncan M, Brush Jr JE, Eisenhofer G 1991a Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst 34:17-36.
135. Goldstein DS, Grossman E, Listwak S, Folio CJ 1991b Sympathetic reactivity during a yohimbine challenge test in essential hypertension. Hypertension 18:III40-III48.
136. Goldstein DS, Grossman E, Tamrat M, Chang PC, Eisenhofer G, Bacher J, Kirk KL, Bacharach S, Kopin IJ 1991c Positron emission imaging of cardiac sympathetic innervation and function using 18F-6-fluorodopamine: effects of chemical sympathectomy by 6-hydroxydopamine. J Hypertension 9:417-423.
137. Goldstein DS, Breier A, Wolkowitz OM, Pickar D, Lenders JW 1992 Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man. Clin Autonom Res 2:359-366.
138. Goldstein DS, Garty M, Bagdy G, Szemeredi K, Sternberg EM, Listwak S, Pacak K, Deka-Starosta A, Hoffman A, Chang PC 1993 Role of CRH in glucopenia-induced adrenomedullary activation in rats. J Neuroendocrinol 5:475-486.
139. Goldstein DS, Vernikos J, Holmes C, Convertino VA 1995 Catecholaminergic effects of prolonged head-down bed rest. J Appl Physiol 78:1023-1029.
140. Goldstein DS, Holmes C, Cannon III RO, Eisenhofer G, Kopin IJ 1997 Sympathetic cardioneuropathy in dysautonomia. N Engl J Med 336:696-702.
141. Goldstein DS, Swoboda KJ, Miles JM, Coppack SW, Aneman A, Holmes C, Lamensdorf I, Eisenhofer G 1999 Sources and physiological significance of plasma dopamine sulfate. J Clin Endocrinol Metab 84:2523-2531.
142. Goldstein DS, Tack C, Li S-T 2000a Sympathetic innervation and function in reflex sympathetic dystrophy. Ann Neurol 48:49-59.
143. Goldstein DS, Holmes C, Li S-T, Bruce S, Metman LV, Cannon III RO 2000b Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338-347.
144. Gordon EK, Markey SP, Sherman RL, Kopin IJ 1976 Conjugated 3,4-dihydroxy phenyl acetic acid (dopac) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment. Life Sci 18:1285-1292.
145. Graham-Pole J, Salmi T, Anton AH, Abramowsky C, Gross S 1983 Tumor and urine catecholamines (CATs) in neurogenic tumors. Correlations with other prognostic factors and survival. Cancer 51:834-839.
146. Greenberg RE, Gardner LI 1960 Catecholamine metabolism in a functional neural tumor. J Clin Invest 39:1729-1736.
147. Grossman E, Hoffman A, Chang PC, Keiser HR, Goldstein DS 1990 Increased spillover of dopa into arterial blood during dietary salt loading. Clin Sci 78:423-429.
148. Grossman E, Goldstein DS, Hoffman A, Wacks IR, Epstein M 1992a Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans. Am J Physiol (Regulatory Integrative Comp Physiol) 262:R993-R999.
149. Grossman E, Hoffman A, Armando I, Abassi Z, Kopin IJ, Goldstein DS 1992b Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats. Clin Sci 83:65-74.
150. Hammerstad JP, Woodward WR, Gliessman P, Boucher B, Nutt JG 1990 L-Dopa Pharmacokinetics in plasma and cisternal and lumbar cerebrospinal fluid of monkeys. Ann Neurol 27:495-499.
151. Hansell P, Kallskog O, Wolgast M 1996 The adrenal glands as suppliers of plasma L-Dopa and sources of urinary dopamine. Kidney & blood Press Res 19:109-114.
152. Hare TA, Beasley BL, Chambers RA, Boehme DH, Vogel WH 1973 DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with Parkinson's disease before and during treatment with L-DOPA. Clin Chim Acta 45:273-280.
153. Hartling OJ, Kelbaek H, Gjorup T, Nielsen MD, Trap-Jensen J 1989 Plasma concentrations of adrenaline, noradrenaline and dopamine during forearm dynamic exercise. Clin Physiol 9:399-404.
154. Hashizume K, Yamatodani A, Yamamoto T, Ogihara T, Kumahara Y, Wada H 1987 Effects of oral and intravenous administrations of dopamine and L-dopa on plasma levels of two isomers of dopamine sulfate in man. Life Sci 41:2697-2704.
155. Helson L, Johnson GA, Smith R 1980 DOPA metabolism in neuroblastoma. Med Pediatr Oncol 8:317-322.
156. Henriksen JH, Christensen NJ 1989 Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance. Am J Physiol (Endocrinol Metab) 257:E743-E750.
157. Higa S, Suzuki T, Hayashi A, Tsuge I, Yamamura Y 1977 Isolation of catecholamines in biological fluids by boric acid gel. Anal Biochem 77:18-24.
158. Hjemdahl P 1984a Catecholamine measurements by high-performance liquid chromato-graphy. Am J Physiol (Endocrinol Metab) 247:E13-E20.
159. Hjemdahl P 1984b Inter-laboratory comparison of plasma catecholamine determinations using several different assays. Acta Physiol Scand suppl. 527:43-54.
160. Hjemdahl P 1987 Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. In: Kaufman S (ed) Metabolism of aromatic amino acids. Methods of enzymology. Academic Press, New York:521-534.
161. Hjemdahl P 1993 Plasma catecholamines-analytical challenges and physiological limitations. Baillière's Clin Endocrinol Metab 7:307-353.
162. Hjemdahl P, Daleskog M, Kahan T 1979 Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 25: 131-138
163. Hjemdahl P, Freyschuss U, Juhlin-Dannfelt A, Linde B 1984 Differentiated sympathetic activation during mental stress evoked by the Stroop test. Acta Physiol Scand Suppl 527:25-29.
164. Hoeldtke R, Baliga BS, Issenberg P, Wurtman RJ 1972 Dihydroxyphenylalanine in rat food containing wheat and oats. Science 175:761-762.
165. Hokfelt B, Hedeland H, Hansson BG 1975 The effect of clonidine and penbutolol, respectively on catecholamines in blood and urine, plasma renin activity and urinary aldosterone in hypertensive patients. Arch Int Pharmacodyn Ther 213:307-321.
166. Hollunger G, Persson SA 1974 The formation in vivo of
167. Holmes C, Eisenhofer G, Goldstein DS 1994 Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr 653:131-138.
168. Horn M, Blatt J 1992 Continued remission in children with neuroblastoma despite elevations of urinary catecholamine metabolites. Am J Pediatr Hematol Oncol 14:202-206.
169. Hovevey-Sion D, Kopin IJ, Stull RW, Goldstein DS 1989 Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology 28:791-797.
170. Howes LG, Hawksby CC, Reid JL 1986 Comparison of plasma 3,4-dihydroxyphenylethylene glycol (DHPG) and norepinephrine levels as indices of sympathetic activity in man. Eur J Clin Invest 16:18-21.
171. Hugh D, Grennan A, Abugila MA, Weinkove C 1987 Ascorbic acid as an antioxidant in measurements of catecholamines in plasma. Clin Chem 33:569-571.
172. Hunneman DH, Jonas W, Gabriel M, Gahr M 1986 Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma. Eur J Pediatr 145:555-557.
173. Hutson PH, Curzon G 1986 Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones. J Neurochem 46:186-190.
174. Hyland K, Surtees RA, Rodeck C, Clayton PT 1992 Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 42:1980-1988.
175. Ikeda H, Suzuki N, Takahashi A, Kuroiwa M, Matsuyama S 1996 3,4-dihydroxyphenylalanine (DOPA) metabolism in screening-detected and nonscreening-detected neuroblastoma. Pediatr Hematol Oncol 13:21-32.
176. Imashuku S, LaBrosse EH 1971 Metabolism of L-3,4-dihydroxyphenylalanine-2,5,6-3H and 3,4-dihydroxyphenylethylamine-2-14C in a patient with neuroblastoma. J Clin Endocrinol Metab 32:241-253.
177. Isaacs H, Medalie M, Politzer WM 1959 Noradrenaline secreting neuroblastoma. BMJ 1:401-404.
178. Jacobsen TN 1996 Sympathetic reflex regulation of the peripheral circulation in humans. Dan Med Bull 43:126-140.
179. Jensen EW 1999 Sympathetic activity and aging: relationship to smoking habits, physical fitness, blood volume, and intracellular signalling. Dan Med Bull 46:106-117.
180. Jeon H-K, Nohta H, Ohkura Y 1992 High-performance liquid chromatographic determination of catecholamines and their precursor and metabolites in human urine and plasma by postcolumn derivatization involving oxidation followed by fluorescence reaction. Anal Biochem 200:332-338.
181. Johnson GA, Gren JM, Kupiecki R 1978 Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine). Clin Chem 24:1927-1930.
182. Johnson GA, Baker CA, Smith RT 1980 Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma. Life Sci 26:1591-1598.
183. Jouve J, Bakri D, Herault J, Muh JP 1991 Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection. J Chromatogr 567:331-341.
184. Kaagedal B, Goldstein DS 1988 Catecholamines and their metabolites. J Chromatogr 429:177-233.
185. Kaakkola S, Tuomainen P, Männistö PT, Palo J 1993 Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias. Acta Neurol Scand 87:309-311.
186. Kanazawa K, Sakakibara H 2000 High content of dopamine, a strong antioxidant, in Cavendish banana. J Agric Food Chem 48:844-848.
187. Kawamura M, Schwartz JP, Nomura T, Kopin IJ, Goldstein DS, Huynh T-T, Hooper DR, Harvey-White J, Eisenhofer G 1999 Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and dopa in peripheral tissues of rats. Neurochem Res 24:25-32.
188. Kehr W, Carlsson A, Lindqvist M 1972 A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch Pharmacol 274:273-280.
189. Kish SJ, Robitaille Y, el-Awar M, Clark B, Ball MJ, Young LT, Currier R, Shannak K 1992 Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology 42:1573-1577.
190. Kobayashi K, Morita S, Sawada H, Mizuguchi T, Yamada K, Nagatsu I, Hata T, Watanabe Y, Fujita K, Nagatsu T 1995 Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 270:27235-27243.
191. Kontras SB 1962 Urinary excretion of 3-methoxy-4-hydroxymandelic acid in children with neuroblastoma. Cancer 15:978-986.
192. Kopin IJ 1985 Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333-364.
193. Koyama E, Minegishi A, Ishizaki T 1988 Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease. Clin Chem 34:680-684.
194. Krstulovic AM 1982 Investigations of catecholamine metabolism using high-performance liquid chromatography. Analytical methodology and clinical applications. J Chromatogr 229:1-34.
195. Kuchel O 1998 Differential catecholamine responses to protein intake in healthy and hypertensive subjects. Am J Physiol (Regulatory Integrative Comp Physiol) 275:R1164-R1173.
196. Kuchel O, Buu NT, Unger T, Lis M, Genest J 1979 Free and conjugated plasma and urinary dopamine in human hypertension. J Clin Endocrinol Metab 48:425-429.
197. Kuchel O, Buu NT, Serri O 1982 Sulfoconjugation of catecholamines, nutrition, and hypertension. Hypertension 4(suppl III):III-93-III-98.
198. Kuchel O, Buu NT 1983 Conjugated catecholamines and their measurement: some pharmacokinetic aspects. Curr Med Res Opin 8 suppl 3:3-8.
199. Kuchel O, Buu NT, Hamet P, Larochelle P, Gutkowska J, Schiffrin EL, Bourque M, Genest J 1985a Orthostatic hypotension: a posture-induced hyperdopaminergic state. Am J Med Sci 289:3-11.
200. Kuchel O, Buu NT, Neemeh J 1985b The platelet phenolsulfotransferase is not indispensable for the sulfoconjugation of plasma catecholamines. Endocr Res 11:225-232.
201. Kuchel O, Buu NT, Tenneson S 1985c CSF sulfoconjugated catecholamines in man: their relationship with plasma catecholamines. J Neural Transmission 62:91-97.
202. Kuchel O, Buu NT 1985 Circadian variations of free and sulfoconjugated catecholamines in normal subjects. Endocr Res 11:17-25.
203. Kuchel O, Buu NT, Edwards DJ 1990 Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. J Lab Clin Med 115:449-453.
204. Kuruma I, Bartholini G, Tissot R, Fletscher A 1972 Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J Pharm Pharmacol 24:289-294.
205. Kvetnansky R, Armando I, Weise VK, Holmes C, Fukuhara K, Deka-Starosta A, Kopin IJ, Goldstein DS 1992a Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation. J Pharmacol Exp Ther 261:899-909.
206. Kvetnansky R, Goldstein DS, Weise VK, Holmes C, Szemeredi K, Bagdy G, Kopin IJ 1992b Effects of handling or immobilization on plasma levels of 3,4- dihydroxyphenylalanine, catecholamines, and metabolites in rats. J Neurochem 58:2296-2302.
207. LaBrosse EH, Com-Nougue C, Zucker JM, Comoy E, Bohuon C, Lemerle J, Schweisguth O 1980 Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 40:1995-2001.
208. Lake CR, Ziegler MG, Kopin IJ 1976 Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci 18:1315-1326.
209. Lake CR, Ziegler MG 1985 Techniques for the assessment and interpretation of catecholamine measurements in neuropsychiatric patients. In: Lake CR, Ziegler MG (eds) The Catecholamines in Psychiatric and Neurologic Disorders.Butterworth, Boston1-34.
210. Laug WE, Siegel SE, Shaw KN, Landing B, Baptista J, Gutenstein M 1978 Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma. Pediatrics 62:77-83.
211. Laxmyr L 1985 Tyrosine Hydroxylase Activity in the Central Nervous System of the Crayfish Pacifastacus-Leniusculus Crustacea Decapoda. J Comp Physiol B 155:603-609.
212. Lee M, Nohta H, Ohtsubo K, Yoo B, Ohkura Y 1987 Determination of L-3,4-dihydroxyphenylalanine in plasma and urine by high-performance liquid chromatography with fluorescence detection. Chem Pharm Bull 35:235-240.
213. Lee MR 1993 Dopamine and the kidney: ten years on (editorial). Clin Sci 84:357-375.
214. Leung A, Shapiro B, Hattner R, Kim E, de Kraker J, Ghazzar N, Hartmann O, Hoefnagel CA, Jamadar DA, Kloos R, Lizotte P, Lumbroso J, Rufini V, Shulkin BL, Sisson JC, Thein A, Troncone L 1997 Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 38: 1352-1357.
215. LeWitt PA 1993 Assessment of the dopaminergic lesion in Parkinson's disease by CSF markers. Adv Neurol 60:544-547.
216. LeWitt PA, Galloway MP, Matson W, Milbury P, McDermott M, Srivastava DK, Oakes D 1992 Markers of dopamine metabolism in Parkinson's disease. The Parkinson Study Group. Neurology 42:2111-2117.
217. Liebner EJ, Rosenthal IM 1973 Serial catecholamines in the radiation management of children with neuroblastoma. Cancer 32:623-633.
218. Linares OA, Jacquez JA, Zech LA, Smith MJ, Sanfield JA, Morrow LA, Rosen SG, Halter JB 1987 Norepinephrine metabolism in humans. J Clin Invest 80:1332-1341.
219. Linden IB 1980 Effects of 3,4-dihydroxyphenylpyruvic acid and L-glutamic acid on some pharmacokinetic parameters of L-dopa in the rat. J Pharm Pharmacol 32:344-348.
220. Lucas K, Gula MJ, Knisely AS, Virgi MA, Wollman M, Blatt J 1994 Catecholamine metabolites in ganglioneuroma. Med Pediatr Oncol 22:240-243.
221. Macdonald IA, Lake DM 1985 An improved technique for extracting catecholamines from body fluids. J Neurosci Methods 13:239-248.
222. Martignoni E, Blandini F, Petraglia F, Pacchetti C, Bono G, Nappi G 1992 Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. J Neural Transmission 4:191-205.
223. Mason GA, Hart-Mercer J, Millar EJ, Strang LB, Wynne NA 1957 Adrenaline secreting neuroblastoma in infant. Lancet 2:322-325.
224. Masserano JM, Vulliet PR, Weiner N 1988 The role of tyrosine hydroxylase in the regulation of catecholamine synthesis. In: Trendelenburg U, Weiner N (eds) Catecholamines II.Springer-Verlag, Berlin427-469.
225. McCulloch RK, Vandongen R, Tunney AM, Beilin LJ, Rogers PB 1987 Distribution of free and sulfate-conjugated catecholamines in human platelets. Am J Physiol (Endocrinol Metab) 253:E312-E316.
226. Mefford IN 1981 Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods 3:207-224.
227. Mefford IN, Ward MM, Miles L, Taylor B, Chesney MA, Keegan DL, Barchas JD 1981 Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continously collected human plasma by high performance liquid chromatography with electrochemical detection. Life Sci 28:477-483.
228. Mena MA, Aguado EG, Yebenes JGd 1984 Monoamine metabolites in human cerebrospinal fluid.HPLC/ED method. Acta Neurol Scand 69:218-225.
229. Meredith IT, Esler MD, Cox HS, Lambert GW, Jennings GL, Eisenhofer G 1991 Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure. Clin Autonom Res 1:187-194.
230. Mezey E, Eisenhofer G, Harta G, Hansson S, Gould L, Hunyady B, Hoffman BJ 1996 A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci U S A 93:10377-10382.
231. Mezey E, Eisenhofer G, Hansson S, Hunyady B, Hoffman BJ 1998 Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat. Neuroendocrinol 67:336-348.
232. Mitjavila M 2002 Meta-iodobenzylguanidine in neuroblastoma: from diagnosis to therapy. Nucl Med Commun 23:3-4.
233. Moleman P, Borstrok JJM 1985 Analysis of urinary catecholamines and metabolites with high-performance liquid chromatography and electrochemical detection. Biog Amines 3:33-71.
234. Morita M, Minami M, Inagaki H 1992 Kinetics of plasma 3,4-dihydroxyphenylalanine (DOPA) during physical exercise: a comparative study with that of plasma noradrenaline. Biog Amines 8:431-441.
235. Moyer TP, Jiang NS 1978 Optimized isocratic conditions for analysis of catecholamines by high-performance reversed-phase paired-ion chromatography with amperometric detection. J Chromatogr 153:365-372.
236. Moyer TP, Jiang NS, Tyce GM, Sheps SG 1979 Analysis for urinary catecholamines by liquid chromatography with amperometric detection: methodology and clinical interpretation of results. Clin Chem 25:256-263.
237. Nagatsu T, Levitt M, Udenfriend S 1964 Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910-2917.
238. Nakaya Y, Katayama T, Nomura M, Ishimura Y, Ohuchi T, Oka M, Yamamoto M, Mizobuchi S 1994 Pathophysiologic significance of free and conjugated dopamines in congestive heart failure. Am Heart J 127:613-617.
239. Nishi M, Miyake H, Takeda T, Hanai J, Fujita K, Ichimiya H, Tanaka T, Hirama T, Ishikawa Y, Kudoh T, Azuma H, Takase A 1998 The relationship between homovanillic/ vanillylmandelic acid ratios and prognosis in neuroblastoma. Onc Rep 5:631-633.
240. Nishihira H, Toyoda Y, Tanaka Y, Ijiri R, Aida N, Takeuchi M, Ohnuma K, Kigasawa H, Kato K, Nishi T 2000 Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution. J Clin Oncol 18:3012-3017.
241. O'Hare JA, Minaker KL, Meneilly GS, Rowe JW, Pallotta JA, Young JB 1989 Effect of insulin on plasma norepinephrine and 3,4-dihydroxyphenylalanine in obese men. Metabolism 38:322-329.
242. O'Meara A, Tormey W, FitzGerald RJ, Fitzgibbon M, Kenny D 1994 Interpretation of random urinary catecholamines and their metabolites in neuroblastoma. Acta Paediatr 83:88-92.
243. Odink J, Van der Beek EJ, van den Berg H, Bogaards JJP, Thissen JTNM 1986 Effect of work load on free and sulfate-conjugated plasma catecholamines, prolactin, and cortisol. Int J Sports Med 7:352-357.
244. Ogaki T, Saito A, Kanaya S, Fujino T 1995 Plasma sulpho-conjugated catecholamine dynamics up to 8 h after 60-min exercise at 50% and 70% maximal oxygen uptakes. Eur J Appl Physiol 72:6-11.
245. Oka M, Ishimura Y, Tsunematsu T, Minakuchi K, Ohuchi T, Matsumoto K 1987 Effects of administration of dopamine and L-DOPA to dogs on their plasma level of dopamine sulfate. Biochem Pharmacol 36:3205-3208.
246. Okuyama C, Ushijima Y, Kubota T, Nakamura T, Kikkawa M, Nishimura T 2002 Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma. Nucl Med Commun 23:663-672.
247. Ordonez LA, Arbrus M, Boyson S, Goodman MN, Ruderman NB, Wurtman RJ 1974 Skeletal muscle: reservoir for exogenous L-dopa. J Pharmacol Exp Ther 190:187-191.
248. Orozco G, Estrada R, Perry TL, Araña J, Fernandez R, Gonzalez-Quevedo A, Galarraga J, Hansen S 1989 Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings. J Neurol Sci 93:37-50
249. Owen MD, Bouquillon AI 1992 The synthesis of l-dihydroxyphenylalanine (L-DOPA) in the cerebral ganglia of the cockroach, periplaneta americana L. Insect Biochem Molec Biol 22:193-198.
250. Ozawa Y, Yoshizumi M, Inui D, Tsuchiya K, Houchi H, Tamaki T, Minakuchi K 1999 Plasma levels of free and sulfoconjugated catecholamines in patients with atherosclerosis. Biol Pharm Bull 22:657-659.
251. Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A, Cohn SL 1999 Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol 21:13-18.
252. Pettersson J, Hussi E, Janne J 1980 Stability of human plasma catecholamines. Scand J Clin Lab Invest 40:297-303.
253. Peuler JD, Johnson GA 1977 Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625-636.
254. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS 1976 Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. Drugs 11:329-377.
255. Pletscher A, Bartholini G, Tohgi H 1967 Metabolic fater of L-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. Brain Res 4:106-109.
256. Pomerantz SH 1966 The tyrosine hydroxylase activity of mammalian tyrosinase. J Biol Chem 241:161-168.
257. Premel-Cabic A, Allain P 1988 Simultaneous liquid chromatographic determination of norepinephrine, 3,4-dihydroxyphenylethyleneglycol, 3,4-dihydroxyphenylalanine and 3,4-dihydroxyphenylacetic acid in human plasma. J Chromatogr 434:187-190.
258. Pritchard J, Barnes J, Germond S, Hartman O, de Kraker J, Lewis I, Lockwood L, Wallendszus K 1989 Stage and urinary catecholamine metabolite excretion in neuroblastoma (Letter). Lancet 2:514-515.
259. Quik M, Sourkes TL 1977 Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase. J Neurochem 28:137-147.
260. Raskind MA, Peskind ER, Veith RC, Beard JC, Gumbrecht G, Halter JB 1988 Increased plasma and cerebrospinal fluid norepinephrine in older men: differential suppression by clonidine. J Clin Endocrinol Metab 66:438-443.
261. Raskind MA, Peskind ER, Holmes C, Goldstein DS 1999 Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biol Psychiatry 46:756-765.
262. Ratge D, Knoll E, Wisser H 1986a Plasma free and conjugated catecholamines in clinical disorders. Life Sci 39:557-564.
263. Ratge D, Gehrke A, Melzner I, Wisser H 1986b Free and conjugated catecholamines in human plasma during physical exercise. Clin Exp Pharmacol Physiol 13:543-553.
264. Ratge D, Kohse KP, Steegmüller U, Wisser H 1991 Distribution of free and conjugated catecholamines between plasma, platelets and erytrocytes: different effects of intravenous and oral catecholamine administrations. J Pharmacol Exp Ther 257:232-238.
265. Rea RF, Wallin BG 1989 Sympathetic nerve activity in arm and leg muscles during lower body negative pressure in humans. J Appl Physiol 66:2778-2781.
266. Rein G, Glover V, Sandler M 1981 Sulphate conjugation of biologically active monoamines and their metabolites by human platelet phenolsulphotransferase. Clin Chim Acta 111:247-256
267. Richter EA, Galbo H, Sonne B, Holst JJ, Christensen NJ 1980 Adrenal medullary control of muscular and hepatic glycogenolysis and of pancreatic hormonal secretion in exercising rats. Acta Physiol Scand 108:235-242.
268. Riederer P, Rausch WD, Birkmayer W, Jellinger K, Seemann D 1978 CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies. J Neural Transmission (Suppl)121-131.
269. Rios M, Habecker B, Sasaoka T, Eisenhofer G, Tian H, Landis S, Chikaraishi D, Roffler-Tarlov S 1999 Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase. J Neurosci 19:3519-3526.
270. Rogers PJ, Tyce GM, Weinshilboum RM, O'Connor DT, Bailey KR, Bove AA 1991 Catecholamine metabolic pathways and exercise training. Plasma and urine catecholamines, metabolic enzymes, and chromogranin-A. Circulation 84:2346-2356.
271. Romero JA, Lytle LD, Ordonez LA, Wurtman RJ 1973 Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues. J Pharmacol Exp Ther 184:67-72.
272. Rose S, Jenner P, Marsden CD 1988 The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats. Mov Disord 3:117-125.
273. Rose S, Jenner P, Marsden CD 1994 Chronic administration does not alter the accumulation of L-dopa into muscle. Mov Disord 9:167-172.
274. Rumley AG 1988 The in vitro stability of catecholamines in whole blood. Ann Clin Biochem 25:585-586.
275. Sagnol M, Claustre J, Cottet-Emard JM, Pequignot JM, Fellmann N, Coudert J, Peyrin L 1990 Plasma free and sulphated catecholamines after ultra-long exercise and recovery. Eur J Appl Physiol 60:91-97.
276. Sakai T, Maeda H, Matsumoto N, Miura S, Kinoshita A, Sasaguri M, Ideishi M, Tanaka H, Shindo M, Arakawa K 1995 Plasma free and sulfoconjugated dopamine before and after a half-marathon. Hypertens Res 18 Suppl 1:S161-S163.
277. Saura J, Nadal E, van den Berg B, Vila M, Bombi JA, Mahy N 1996 Localization of monoamine oxidases in human peripheral tissues. Life Sci 59:1341-1349.
278. Sawada T 1997 Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors. Pediatr Hematol Oncol 14:291-293.
279. Scheinin M 1985 Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Med Biol 63:1-17.
280. Schmiegelow K, Simes MA, Agertoft L, Berglund G, Storm-Mathisen I, Andreassen M, Salmi TT, Nygsrd R, Wiebe T, Kreuger A 1989 Radio-iodobenzylguanidine scintigraphy of neuroblastoma: conflicting results, when compared with standard investigations. Med Pediatr Oncol 17:127-130.
281. Shannon JR, Robertson D 1996 The clinical utility of plasma catecholamines (editorial). J Lab Clin Med 128:450-451.
282. Sharpless NS, Ericsson AD, McCann DS 1971 Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L-3,4-dihydroxyphenylalanine (L-dopa). Neurology 21:540-549.
283. Shibata O, Morooka H, Hara K, Hasheba S, Gotoh Y, Ozaki M 1987 Free and conjugated catecholamine concentrations in human small intestine following exogenous free dopamine administration. Biog Amines 4:465-472
284. Shulkin BL, Shapiro B 1998 Current concepts on the diagnostic use of MIBG in children. J Nucl Med 39:679-688.
285. Shum A, Van Loon GR, Sole MJ 1982 Measurement of l-dihydroxyphenylalanine in plasma and other biological fluids by high pressure liquid chromatography with electrochemical detection. Life Sci 31:1541-1545.
286. Smedes F, Kraak JC, Poppe H 1982 Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 231:25-39.
287. Snider SR, Kuchel O 1983 Dopamine: An important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for human stress response and hypertension. Endocr Rev 4:291-309.
288. Sothmann MS, Gustafson AB, Chandler M 1987 Plasma free and sulfoconjugated catecholamine responses to varying exercise intensity. J Appl Physiol 63:654-658.
289. Sothmann MS, Blaney J, Woulfe T, Donahue-Fuhrman S, Lefever K, Gustafson AB, Murthy VS 1990 Plasma free and sulfoconjugated catecholamine during sustained exercise. J Appl Physiol 68:452-456.
290. Sourkes TL, Denton RL, Murphy GF, Chavez B, Saint Cyr S 1963 The excretion of dihydroxyphenylalanine, dopamine, and dihydroxyphenylacetic acid in neuroblastoma. Pediatrics 31:660-668.
291. Stahl SM, Faull KF, Barchas JD, Berger PA 1985 CSF monoamine metabolites in movement disorders and normal aging. Arch Neurol 42:166-169.
292. Sundaram RS, van Loon JA, Tucker R, Weinshilboum RM 1989 Sulfation pharmacogenetics: correlation of human platelet and small intestinal phenol sulfotransferase. Clin Pharmacol Ther 46:501-509.
293. Swoboda KJ, Hyland K, Goldstein DS, Kuban KC, Arnold LA, Holmes CS, Levy HL 1999 Clinical and therapeutic observations in aromatic L-amino acid decarboxylase deficiency. Neurology 53:1205-1211.
294. Szemeredi K, Pacak K, Kopin IJ, Goldstein DS 1991 Sympathoneural and skeletal muscle contributions to plasma dopa responses in pithed rats. J Auton Nerv Syst 35:169-174.
295. Tang QM, Xu XR, Shi YQ, Jin BX 1986 Determination of serum catecholamine metabolites in neuroblastoma by high performance liquid chromatography with electrochemical detection. Biomed Chromatogr 1:7-11.
296. Teychenne PF, Feuerstein G, Lake CR, Ziegler MG 1985 Central catecholamine systems: interaction with neurotransmitters in normal subjects and in patients with selected neurologic diseases. In: Lake CR, Ziegler MG (eds) The Catecholamines in Psychiatric and Neurologic Disorders. Butterworth, Boston91-119.
297. Thiede HM, Kehr W 1981 Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples. Naunyn-Schmiedeberg's Arch Pharmacol 318:19-28.
298. Thoenen H, Tranzer JP 1968 Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedeberg's Arch Pharmacol 261:271-288.
299. Thorner MO 1975 Dopamine is an important neurotransmitter in the autonomic nervous system. Lancet 1:662-665.
300. Tohgi H, Abe T, Takahashi S, Ueno M, Nozaki Y 1990 Cerebrospinal fluid dopamine, norepinephrine, and epinephrine concentrations in Parkinson's disease correlated with clinical symptoms. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH (eds) Advances in Neurology, Vol 53: Parkinson's disease: Anatomy, Pathology, and Therapy.Raven Press, New York: 277-282.
301. Tohgi H, Abe T, Takahashi S, Nozaki Y, Kikuchi T 1991 Concentrations of tyrosine, L-dihydroxyphenylalanine, dopamine, and 3-O-methyldopa in cerebrospinal fluid of Parkinson's disease. Neurosci Letters 127:212-214.
302. Tohgi H, Abe T, Takahashi S, Takahashi J, Nozaki Y, Ueno M, Kikuchi T 1993 Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes. J Neural Transmission 5:17-26.
303. Toth LA, Scott MC, Elchisak MA 1986 Dopamine sulfate formation and phenol sulfotransferase activity in dog and human platelets. Life Sci 39:519-526.
304. Triggs EJ, Charles BG, Contin M, Martinelli P, Cortelli P, Riva R, Albani F, Baruzzi A 1996 Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients. Eur J Clin Pharmacol 51:59-67.
305. Tuchman M, Ramnaraine ML, Woods WG, Krivit W 1987 Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics 79:203-205.
306. Turkka JT, Juujärvi KK, Myllylä VV 1987 Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease. Eur Neurol 26:29-34.
307. Tyce GM, Rorie DK, Byer DE, Danielson DR 1985 Free and conjugated amines in human lumbar cerebrospinal fluid. J Neurochem 44:322-324.
308. Tyce GM, Van Dyke RA, Rettke SR, Atchison SR, Wiesner RH, Dickson ER, Krom RA 1987 Human liver and conjugation of catecholamines. J Lab Clin Med 109:532-537.
309. Türler K, Käser H 1971 Quantitative fluorimetric determination of urinary dopa and its significance for the diagnosis of neural crest tumours. Clin Chim Acta 32:41-51.
310. Udenfriend S 1966 Tyrosine hydroxylase. Pharmacol Rev 18:43-51.
311. Veith RC, Best JD, Halter JB 1984 Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. J Clin Endocrinol Metab 59:151-155.
312. Vendsalu A 1960 Studies on adrenaline and noradrenaline in human plasma. Acta Physiol Scand 49, suppl. 173:1-123.
313. Vissing SF 1997 Differential activation of sympathetic discharge to skin and skeletal muscle in humans. Acta Physiol Scand 161, suppl. 639:1-32.
314. Von Studnitz W 1960 Methodische und klinische Untersuchungen über die Ausscheidung der 3-methoxy-4-hydroxymandelsäure im Urin. Scand J Clin Lab Invest 12 suppl 48:1-73.
315. Von Studnitz W, Käser H, Sjoerdsma A 1963 Spectrum of catechol amine biochemistry in patients with neuroblastoma. N Engl J Med 269:232-235.
316. Voorhess ML, Gardner LI 1961 Urinary excretion of norepinephrine, epinephrine and 3-methoxy-4-hydroxymandelic acid by children with neuroblastoma. J Clin Endocrinol Metab 21:321-335.
317. Voorhess ML, Gardner LI 1962 Studies of catecholamine excretion by children with neural tumors. J Clin Endocrinol Metab 22:126-133
318. Waalkes TP, Sjoerdsma A, Creveling CR, Weissbach H, Udenfriend S 1958 Serotonin, norepinephrine, and related compounds in bananas. Science 127:648-650.
319. Waite JH 1991 Detection of peptidyl-3,4-dihydroxyphenylalanine by amino acid analysis and microsequencing techniques. Anal Biochem 192:429-433.
320. Wallin BG, Sundlöf G, Eriksson BM, Dominiak P, Grobecker H, Lindblad LE 1981 Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive man. Acta Physiol Scand 111:69-73.
321. Wang PC, Buu NT, Kuchel O, Genest J 1983 Conjugation Patterns of endogenous plasma catecholamines in human and rat. J Lab Clin Med 101: 141-151.
322. Weicker H 1988 Determination of free and sulfoconjugated catecholamines in plasma and urine by high-performance liquid chromatography. Int J Sports Med 9, suppl.:68-74.
323. Weir TB, Smith CCT, Round JM, Betteridge DJ 1986 Stability of catecholamines in whole blood, plasma, and platelets. Clin Chem 32:882-883
324. Wenk G, Greenland R 1980 Investigations of the performance of a high-performance liquid chromatography system with an electrochemical detector. J Chromatogr 183:261-267.
325. Wester P, Bergström U, Eriksson A, Gezelius C, Hardy J, Winblad B 1990 Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsi cases. J Neurochem 54:1148-1156.
326. Wiesel FA 1975 Mass fragmentographic determination of acidic dopamine metabolites in human cerebrospinal fluid. Neurosci Letters 1:219-224.
327. Wilk S 1986 Tissue analysis. In: Krstulovic AM (ed) Quantitative analysis of catecholamines and related compounds.Ellis Horwood Ltd, Chichester: 357-373.
328. Wilk S, Stanley M 1978 Dopamine metabolites in human brain. Psychopharmacology 57:77-81.
329. Wilkes MM, Babaknia A, Hoff JD, Quigley ME, Kraus PF, Yen SS 1981 Circadian rhythm in circulating concentration of dihydroxyphenylacetic acid in normal women. J Clin Endocrinol Metab 52:608-611.
330. Williams CM, Greer M 1963 Homovanillic acid and vanilmandelic acid in diagnosis of neuroblastoma. JAMA 183:836-840.
331. Williams M, Young JB, Rosa RM, Gunn S, Epstein FH, Landsberg L 1986 Effect of protein ingestion on urinary dopamine excretion.Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man. J Clin Invest 78:1687-1693.
332. Wolfovitz E, Grossman E, Folio CJ, Keiser HR, Kopin IJ, Goldstein DS 1993 Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans. Clin Sci 84:549-557.
333. Wolfovitz E, Pacak K, Abassi Z, Kopin IJ, Goldstein DS 1995 Effects of hypercortisolemia or hyperinsulinemia on neurochemical indices of catecholamine release and synthesis in conscious rats. J Auton Nerv Syst 54:104-112.
334. Woodward WR, Olanow CW, Beckner RM, Hauser RA, Gauger LL, Cederbaum JM, O'Hare JA 1993 The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients: plasma and ventricular csf L-dopa levels and clinical responses. Neurology 43:1704-1708.
335. Yamamoto T, Polinsky RJ, Goldstein DS, Baucom CE, Kopin IJ 1996 Plasma sulfoconjugated dopamine levels are normal in patients with autonomic failure. J Lab Clin Med 128:488-491.
336. Yoshizumi M, Nakaya Y, Hibino T, Nomura M, Minakuchi K, Kitagawa T, Katoh I, Ohuchi T, Oka M 1992 Changes in plasma free and sulfoconjugated catecholamines before and after acute physical exercise: experimental and clinical studies. Life Sci 51:227-234.
337. Yoshizumi M, Ishimura Y, Masuda Y, Ohuchi T, Katoh I, Houchi H, Oka M 1995 Physiological significance of plasma sulfoconjugated dopamine: experimental and clinical studies. Hypertens Res 18 Suppl 1:S101-S106.
338. Yoshizumi M, Kitagawa T, Hori T, Katoh I, Houchi H, Ohuchi T, Oka M 1996 Physiological significance of plasma sulfoconjugated dopamine in patients with hypertension - clinical and experimental studies. Life Sci 59:324-330.
339. Yoshizumi M, Kitagawa T, Ozawa Y, Tano K, Tsuchiya K, Houchi H, Minakuchi K, Tamaki T 1998 Changes in plasma free and sulfoconjugated catecholamines during the perioperative period of cardiac surgery: effect of continuous infusion of dopamine. Biol Pharm Bull 21:787-791.
340. Ziegler MG, Wood JH, Lake CR, Kopin IJ 1977 Norepinephrine and 3-methoxy-4-hydroxyphenyl glycol gradients in human cerebrospinal fluid. Am J Psychiat 134:565-568.
341. Ziegler MG, Lake CR, Wood JH, Ebert MH 1980 Norepinephrine in cerebrospinal fluid. Basic studies, effets of drugs and disease. In: Wood JH (ed) Neurobiology of Cerebrospinal Fluid.Plenum Press, New York:141-152.
342. Ziegler MG, Woodson LC, Kennedy B 1986 Radioenzymatic assay of catecholamines, metabolites and related enzymes. In: Krstulovic AM (ed) Quantitative analysis of catecholamines and related compounds. Ellis Horwood Ltd, Chichester:263-280.
343. Zivin JA, Reid JL, Saavedra JM, Kopin IJ 1975 Quantitative localization of biogenic amines in the spinal cord. Brain Res 99:293-301.
344. Zubenko GS, Marquis JK, Volicer L, Direnfeld LK, Langlais PJ, Nixon RA 1986 Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study. Biol Psychiatry 21:1365-1381.
345. Zürcher G, Da Prada M 1979 Radioenzymatic assay of femtomole concentrations of DOPA in tissues and body fluids. J Neurochem 33:631-639.
346. Zürcher G, Da Prada M 1990 Simple automated high-performance liquid chromatographic column-switching technique for the measurement of dopa and 3-O-methyldopa in plasma. J Chromatogr 530:253-262.
347. Ørskov L, Jacobsen J, Dupont E, Olivarius BdF, Christensen NJ 1987 Autonomic function in parkinsonian patients relates to duration of disease. Neurology 37:1173-1178.